Home › Acute Lymphoblastic Leukemia › Florida › Cape Coral
Acute Lymphoblastic Leukemia clinical trials in Cape Coral, FL
3 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Cape Coral (within about 30 miles). Open a study to see who can join and how to contact the study team.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Regional Cancer Center-Lee Memorial Health System, Fort Myers · 8 mi away
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs · 19 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Golisano Children's Hospital of Southwest Florida, Fort Myers · 8 mi away
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Golisano Children's Hospital of Southwest Florida, Fort Myers · 8 mi away
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Mountain View, CA13 studies
Other studies in Cape Coral
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer10 studies
- Breast Cancer10 studies
- Alzheimer's Disease9 studies
- Endometrial Cancer7 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Acute Myeloid Leukemia6 studies
- Steatotic Liver Disease6 studies
- Lung Cancer5 studies
- Metastatic Cancer5 studies
- Stomach Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.